维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="Tricoci"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Thrombin-receptor antagonist vorapaxar in acute coronary syndromes显示文摘	TRICOCI P HUANG Z HELD C	2012	N Engl J Med2012，366，1：	1
2	Time to coronary angiography and outcomes among patients with high-risk non-ST-segment-elevation acute coronary syndromes 显示文摘	Tricoci P Lokhnygina Y Berdan LG	2007	Circulation2007，116，：	1
3	Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes(results from CRUSADE)显示文摘	Tricoci P Peterson ED Mulgund J		0，，09：	1
4	Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?显示文摘	Patrí cia O Guimar? es Pierluigi Tricoci	2015	Expert Opinion on Pharmacotherapy2015，，：	1
5	Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (From the TRACER Trial)显示文摘	Kenneth W. Mahaffey Zhen Huang Lars Wallentin Robert F. Storey Lisa K. Jennings Pierluigi Tricoci Harvey D. White Paul W. Armstrong Philip E. Aylward David J. Moliterno Frans Van de Werf Edmond Chen Sergio Leonardi Tyrus Rorick Claes Held John Strony Robe	2013	The American Journal of Cardiology2013，，：	1
6	Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)显示文摘	William Schuyler Jones Pierluigi Tricoci Zhen Huang David J. Moliterno Robert A. Harrington Peter R. Sinnaeve John Strony Frans Van de Werf Harvey D. White Claes Held Paul W. Armstrong Philip E. Aylward Edmond Chen Manesh R. Patel Kenneth W. Mahaffey	2014	American Heart Journal2014，，4：	1
7	Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention 显示文摘	Vergara-Jimenez J Tricoci P	2010	Vasc Health Risk Manag2010，6，3：	1
8	Throm- bin-receptor antagonist vorapaxar in acute coronary syndromes显示文摘	TRICOCI P HUANG Z HELD C	2012	NEnglJ Med2012，366，：	1
9	Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA?CER) trial 显示文摘	LEONARDI S TRICOCI P WHITE H D	2013	Eur Heart J2013，34，23：	1
10	Time to coronary angiography and outcomes among patients with high-risk non ST- segment elevation acute coronary syndromes: results from the SYNERGY trial显示文摘	Tricoci P Lokhnygina Y Berdan LG	2007	Circulation2007，116，23：	1
11	Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome:an analysis from the Early GlycoproteinⅡb/Ⅲa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome(EARLY ACS)trial显示文摘	Wang TY White JA Tricoci P	2011	Circulation2011，123，7：	1
12	Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends显示文摘	Pierluigi Tricoci Sergio Leonardi Jennifer White Harvey D. White Paul W. Armstrong Gilles Montalescot Robert P. Giugliano C. Michael Gibson Frans Van de Werf Robert M. Califf Robert A. Harrington Eugene Braunwald Kenneth W. Mahaffey L. Kristin Newby	2013	Journal of the American College of Cardiology2013，，：	1
13	Scientific evidence underly- ing the ACC/AHA clinical practice guidelines 显示文摘	Tricoci P Allen JM Kramer JM	2009	JAMA2009，301，8：	1
14	Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatmentin patients with acute coronary syndrome: an analysis from the Early Glycoprotein Ⅱb/Ⅲa Inhibition in Patients with Non ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial 显示文摘	Wang TY White JA Tricoci P	2011	Circulation2011，123，7：	1
15	Safety and elficacy of abciximabas an adjunct to percutaneous coronary intervention显示文摘	Vergara-Jimenez J Tricoci P	2010	VaseHealth Risk Manag2010，3，6：	1
16	Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention显示文摘	Pierluigi Tricoci Jennifer Vergara-Jimenez	2010	Vascular Health and Risk Management . 2010 (defa)2010，，：	1
17	Scientific evi?dence underlying the ACC/AHA clinical practice guide?lines显示文摘	Tricoci P Allen JM Kramer JM	2009	JAMA2009，301，8：	1
18	Vorapaxar in acute coronary syndrome patients undergoing coronary artery by- pass graft surgery Subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)显示文摘	Whellan DJ Tricoci P Chen E	2014	J Am Coll Cardiol2014，63，11：	1
19	Thrombin-receptor antagonist vorapaxar in acute coronary syndromes显示文摘	Tricoci P Huang Z Held C	2012	N Engl J Meal2012，366，：	1
20	Safety and efficacy of abciximab as an adjunct to percutaneous coronary inter- vention 显示文摘	VERGARA-JIMENEZ J TRICOCI P	2010	Vasc Health Risk Manag2010，6，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示